Alternative method for the evaluation of monovalent inactivated foot and mouth disease virus vaccine

• Main Authors: M.S. Abousenna, Heba A. Khafagy, Mahmoud M. Abotaleb, D.M. Darwish, Barghooth W.M., Nermeen G. Shafik
• Format: Article
• Language: English
• Published: Finlay Ediciones 2021-02-01
• Series: VacciMonitor
• Subjects: foot-and-mouth disease; benzyl alcohol; enzyme-linked immunosorbent assay; in vitro techniques; vaccine potency
• Online Access: http://scielo.sld.cu/scielo.php?script=sci_abstract&pid=S1025-028X2021000100004&lng=es&nrm=iso&tlng=es
• ISSN: 1025-028X; 1025-0298

Foot and mouth disease is a highly contagious viral disease of cloven-hoofed animals that has a significant economic impact on livestock. A recent outbreak was detected and recorded as exotic strain of foot and mouth disease virus SAT2 (Serotype SAT2, topotype VII, Lib-12 lineage). The emergency vaccine was produced and assessed in vivo and large number of vaccine batches were urgently needed. The present work was aimed to provide a rapid evaluation of inactivated foot and mouth disease SAT2 oily vaccine to exclude the unsatisfactory batches during emergency circumstances and to reduce time, effort and cost. The extraction of foot and mouth disease antigen content from oily adjuvanted vaccine was carried out using isopropyl myristate and benzyl alcohol methods. The extracted viral antigen was identified by foot and mouse disease serotyping ELISA and 146S content was quantified using sucrose density gradient analysis. Evaluations were carried out instantly and at 2h, 6h and 24h. The results indicated the efficiency of benzyl alcohol to breakdown the oil emulsion either MONTANIDE™ ISA 206 VG or MONTANIDE™ ISA 50 V2, while the isopropyl myristate was efficient for MONTANIDE™ ISA 50 V2 only. The identification and quantification of 146S for extracted antigen using benzyl alcohol indicated significant stable records at different time intervals for the vaccine batches, while the extraction using isopropyl myristate indicated unstable records at different time intervals. It was concluded that the evaluation of monovalent foot and mouse disease vaccine could be conducted in vitro, using serotyping ELISA and quantification of 146S for the extracted antigen, either using benzyl alcohol or isopropyl myristate (MONTANIDE™ ISA50 V2 only), with the consideration that 146S content should not less than 4 μg/mL.